CSWM
KNSA icon

Cassady Schiller Wealth Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Cassady Schiller Wealth Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$732 Buy
+37
New +$844 ﹤0.01% 866

Other funds holding KNSA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cassady Schiller Wealth Management's KNSA Position: Q4 2024 in Review

Cassady Schiller Wealth Management opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q4 2024: 37 shares worth $732. The stake represents ﹤0.01% of the portfolio and ranks #866 among its holdings.

160 funds tracked by Wall St. Rank hold KNSA as of Q4 2024.

  • Cassady Schiller Wealth Management held 37 shares of Kiniksa Pharmaceuticals worth $732 as of Q4 2024.
  • Kiniksa Pharmaceuticals was a new Cassady Schiller Wealth Management position in Q4 2024.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #866 holding.
  • 160 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.